GlassScriptPhysician profile
Marian Menezes
NPI 1154439602
$11,243.34
in general payments reported to CMS, 2019-2025
42 companies · $1,176 in 2025
The $1,176 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,479 · 2020: $3,016 · 2021: $1,610 · 2022: $704 · 2023: $1,398 · 2024: $1,860 · 2025: $1,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,176 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,175.97 |
| Education | $257.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $2,195.66 | 2020-2025 | Wakix |
| Astrazeneca Pharmaceuticals LP | $2,140.93 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,668.87 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $979.88 | 2019-2025 | Uptravi, Opsumit |
| Jazz Pharmaceuticals INC. | $839.45 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $480.31 | 2019-2024 | Ofev, Stiolto Respimat |
| Genzyme Corporation | $355.20 | 2020-2024 | |
| Insmed, INC. | $339.75 | 2019-2025 | Arikayce |
| Mylan Specialty L.P. | $206.30 | 2019-2024 | Yupelri |
| Verona Pharma, INC. | $173.58 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $173.27 | 2023-2025 | Winrevair, Belsomra |
| Regeneron Healthcare Solutions, INC. | $152.25 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $121.10 | 2019-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $117.44 | 2023-2025 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $103.02 | 2019-2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $93.43 | 2020-2024 | |
| Philips North America LLC | $91.81 | 2019-2023 | |
| Pulmonx Corporation | $85.29 | 2022-2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Sanofi-Aventis U.S. LLC | $81.96 | 2020-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.58 | 2021-2025 | Glassia |
| Inogen, INC. | $67.47 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Gilead Sciences, INC. | $66.31 | 2021-2023 | |
| Mallinckrodt Hospital Products INC. | $61.47 | 2023-2024 | Acthar |
| Pfizer INC. | $58.94 | 2022-2024 | |
| Ani Pharmaceuticals, INC. | $52.43 | 2024-2025 | Purified Cortrophin Gel |
| Paratek Pharmaceuticals, INC. | $45.76 | 2020-2021 | |
| Baxter Healthcare | $41.54 | 2024-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Resmed Corp | $40.49 | 2023-2025 | |
| Idorsia Pharmaceuticals US INC | $37.23 | 2023 | Quviviq |
| Vanda Pharmaceuticals INC. | $36.50 | 2021 | |
| Inspire Medical Systems, INC. | $35.78 | 2024 | Inspire |
| Axsome Therapeutics, INC. | $27.10 | 2023 | Sunosi |
| Amgen INC. | $26.05 | 2024 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $25.64 | 2020-2021 | |
| Circassia INC. | $24.17 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $23.87 | 2023 | Lumryz |
| Optinose US, INC. | $22.70 | 2022 | |
| Sandoz INC. | $20.08 | 2019 | |
| Horizon Therapeutics Plc | $18.55 | 2022 | |
| Shire North American Group INC | $17.51 | 2019 | |
| Genentech USA, INC. | $15.68 | 2019 | |
| Ambu INC. | $5.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marian Menezes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.